Truveta Data used in new study shows women and Black patients less likely to receive catheter-based treatment for pulmonary embolism
Rod Hochman, MD, president and CEO of Providence, is new Truveta Board of Directors Chair
Real-world prescribing of lecanemab in the United States
Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions
New research uses Truveta Data to study the management of patients with acute heart failure
Expanded clinical notes and medical images available to advance research
Expanding customer options to achieve research success
Truveta wins 2024 Stevie Awards for Most Innovative Company and Achievement in Technology
